Author: healthadmin

New research published in journal alcohol and alcoholism The findings suggest that moderate to heavy drinking tends to be associated with increased inflammation in the body, even in people who maintain a nutritious diet. This study provides evidence that eating well alone may not be enough to counteract the harmful physical effects of frequent alcohol consumption. Scientists Kailyn Roeder and Jimicae Beck-Courtney wanted to better understand how two common lifestyle factors, diet and alcohol intake, interact to influence chronic systemic inflammation. Jimikaye Beck Courtney is an assistant professor and A. Donald and Billy J. Stallings Research Fellow at the University…

As the U.S. population ages, scientists are looking for ways to help people stay healthy later in life. By 2050, nearly one in four Americans will be over the age of 65, with many expected to live into their 90s. Although modern medicine has dramatically extended lifespans, aging still poses serious physical challenges, including weakened immunity, chronic inflammation, bone loss, fatigue, and decreased physical strength. Researchers at the University at Buffalo think they may have found an important clue to slowing down some of the changes associated with aging. Scientists target ‘inflammation’ Aging is often accompanied by an ongoing low-level…

Two months after UCB revealed the success of Bimzerx in a head-to-head trial with AbbVie’s Skyridi in patients with psoriatic arthritis (PsA), the Belgian drugmaker has released detailed results. In a Phase 3B study of 553 patients, 49% of patients in the Bimzelx group experienced a reduction in disease activity at week 16, compared with 38% in the Skyrizi group. The results were deemed statistically significant, UCB said. The primary endpoint of disease activity was measured by ACR50, a composite efficacy measure specified by the American College of Rheumatology. ACR50 indicates a 50% or greater improvement from baseline in the…

Roche has entered into a voluntary licensing agreement to provide the popular anti-influenza virus drug Xofluza (baloxavir marboxil) to generic drug manufacturers in 129 developing countries. MPP said in a May 18 release that the agreement with the Pharmaceutical Patent Pool will enable generic supply of baloxavir in 129 low- and middle-income countries and “support both seasonal influenza and broader pandemic preparedness and response efforts.” The agreement creates “additional supply channels for equitable access, which is particularly important during the pandemic when demand is at its highest,” UN aid agency MPP said in a statement. As part of the agreement…

With questions already swirling about the real affordability impact of the government’s drug purchasing portal TrumpRx, the White House is updating the platform to address key gaps in the drugs on its list, although many caveats remain. The expansion of TrumpRx.gov announced by President Donald Trump on Monday will add more than 600 generic drugs to the platform. The site allows patients to compare covered prices for specific drugs and also provides links to other direct-to-consumer purchasing platforms, such as online pharmacies and pharmacies operated by pharmaceutical companies. When the website launched near the beginning of this year, TrumpRx initially…

New research presented at the European Congress on Obesity (ECO 2026) suggests that losing significant weight while taking popular GLP-1 drugs such as Ozempic, Wigoby, Saxenda, and Munjaro may significantly reduce the risk of several obesity-related health problems. The study results also showed that people who gained weight after starting treatment generally had worse health outcomes. The study was led by Professor John Wilding and colleagues at the University of Liverpool, UK. Significant weight loss leads to improved health GLP-1-based drugs such as semaglutide (Ozempic, Wegovy), liraglutide (Saxenda), and tirzepatide (Mounjaro) are widely used to treat obesity and type 2…

Special operations veterans suffering from traumatic brain injury and post-traumatic stress disorder experienced significant improvement in symptoms after a single dose of the psychoactive drug ibogaine. Brain scans revealed that the treatment was associated with a sustained increase in cerebral blood flow and extensive reorganization of neural networks. The study was published in the journal Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. Sudden blows to the head or exposure to intense blast waves can cause traumatic brain injuries. In combat zones, soldiers are exposed to blast waves that send immense pressure on their skulls, potentially stretching or severing delicate nerve fibers.…

For decades, a puzzling contradiction about tiny subatomic particles called muons fueled speculation that physicists were on the verge of discovering an entirely new force of nature. Now, an international research team led by physicists at Penn State University says the mystery appears to be solved, and the answer supports rather than overturns existing physics. The researchers published their findings in the journal naturedescribes one of the most accurate particle physics calculations ever completed. Their study shows that the long-debated discrepancy between theory and experiment is likely caused by limitations in early calculations rather than evidence of unknown physics. Decades…

Nourish, a metabolism provider focused on virtual nutrition, has raised $100 million in a Series C round. The round was led by Menlo Ventures with participation from Thrive Capital, Index Ventures, JP Morgan Growth Equity Partners, Maverick Ventures, Y Combinator and others. The funding will be used to expand Nourish’s provider workforce, accelerate investments in AI, and deepen partnerships with payers and health systems. The company is pivoting from a dietitian-only nutrition platform to a more comprehensive metabolic health clinic by hiring physicians. Nourish patients are typically paired with a registered dietitian, but lab tests, GLP-1 prescriptions, and other virtual…

Medical devices are becoming increasingly smaller, lighter and more portable. Miniaturization is now a feature of many new medtech products, from handheld diagnostic tools to wearable infusion pumps and compact surgical instruments. While miniaturization provides clear benefits for patients and clinicians, it also introduces mechanical constraints that can impact how reliably these devices operate over time. Here, Chris Johnson, Managing Director of bearing specialist SMB Bearings, explores how mechanical decisions that were once considered secondary can begin to determine the success of an entire product. In emergency medical settings, small equipment can be transported directly to the patient, reducing delays…